TP53 and liver cancer: We performed GSEA analysis of PDCD2L and BTF3 based on the liver cancer transcriptome data from TCGA and found that the p53 pathway was significantly enriched in the low-expression group of BTF3 and PDCD2L (Fig. 6A,B).